ANNUAL REPORT HOME ABOUT GENZYME SITEMAP LEGAL DISCLAIMER 
2005 Annual Report
Genzyme Logo
TABLE OF CONTENTS
25 Years of Inspiration
Financial Highlights
Letter to Shareholders
Commitment Drives Growth
Bringing Myozyme to Market
Expanding Our Renal Franchise
Future Growth Drivers
A Strong Global Infrastructure
2005: The Year in Review
Genetic Diseases
Renal Disease
Orthopaedics
Oncology
Transplant and Immune Diseases
Genetics and Diagnostics
A Portfolio for the Future
Product Development Pipeline
Our Social Responsibility
Preparing for the Future
Commitment Drives Growth

Genzyme's mission is to provide patients with innovative, highly effective therapies and diagnostics. Today, our pipeline contains an unprecedented number of late-stage clinical programs directed at difficult diseases, and we have expanded our global infrastructure to ensure the quality and ample supply of our products. As a result, we expect to launch new products and extend existing product lines to new markets in order to benefit many more patients and drive our growth for the next 5 years and beyond.

MyozymeRenal Franchise
Late-Stage PipelineGlobal Infrastructure